Skip to main content
Premium Trial:

Request an Annual Quote

Eric Topol, Michael Stapleton, Vivien Bonazzi, Clive Seymour

Premium

Eric Topol has been appointed to the scientific advisory board of Perlegen. He is chief academic officer of The Cleveland Clinic Foundation and provost of the Cleveland Clinic Lerner College of Medicine of Case Western University.


Michael Stapleton has become general manager and vice president, and Vivien Bonazzi director of research and development at Invitrogen’s bioinformatics business. Stapleton previously worked at Accelrys, where he was executive vice president and COO. He holds a doctorate and master’s degrees in chemical physics, and a bachelor’s degree in chemistry from Southampton University in the UK.

Bonazzi joins Invitrogen from Celera Genomics, where she was director of product development and scientific management.


Clive Seymour has become vice president for Asia-Pacific at Bruker BioSciences. Seymour was previously vice president for the Asia-Pacific region at Biacore. Prior to that, he was vice president corporate communications and head of life science research business unit at Biacore. He has also been European market area manager for Pharmacia Biotech Europe, and regional marketing and sales manager for Pharmacia Biotech Asia-Pacific.

 

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.